Trader Joe’s is remembering RxBars due to issues over undeclared peanuts.

On Thursday, the grocery chain and RxBar revealed they were remembering 2 variations of the protein bar as they might include trace quantities of peanuts, which were not pointed out on the list of active ingredients. The impacted bars consist of Chocolate Sea Salt and Coconut Chocolate RxBars.

RxBar stated it determined the capacity for contamination after being gotten in touch with by customers with peanut allergic reactions.

The affected bars were produced throughout 6 days in August, RxBar informed Organisation Expert in a declaration.

“We determined the capacity for peanut in these 2 tastes with ‘Finest By’ dates of June 10, 2019 to June 17, 2019 after getting contacts from customers with peanut allergic reactions,” RxBar stated in a declaration. “No other RxBar tastes or RxBar items are impacted by the recall.”

According to RxBar, nobody has actually been hospitalized after consuming among the possibly polluted bars. The protein bar maker stated it is remembering the bars “out of an abundance of care.”

“Individuals who have an allergic reaction to peanuts risk of severe or lethal allergy if they consume this item,” Trader Joe’s stated in a declaration.

Learn More: More than 12 million pounds of beef are being remembered from Walmart and other shops as a salmonella break out sickens more than 240 individuals

Trader Joe’s and RxBar will offer any consumer who returns the remembered bars a complete refund. RxBar stated that all shops that might be offering the affected items have actually been informed. Possibly impacted items have actually been gotten rid of from sale and damaged.

Trader Joe’s has more details on how to determine whether a bar you purchased has actually been remembered on its site.

The recall is paradoxical, considered that every RxBar notes its core active ingredients on the front of its product packaging. The protein bar has actually established a cult following due to its uncomplicated, natural branding.

Kellogg revealed strategies to get RxBar-maker Chicago Bar Co. for $600 million in October 2017, as the cereal maker tries to include more much healthier choices to its portfolio.